We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Katie Okamoto Katie Okamoto ...
Aston Villa's ninth win in 11 games and their third on the bounce propelled them into the top four of the Premier League. Two goals from Morgan Rogers, who doubled his output for the season, were ...
Three consecutive four-goal home wins have propelled Birmingham City right back into the play-off conversation. Just a few weeks ago Chris Davies' side were sitting in 15th and while not exactly ...
A24 has dropped the first fun and stylish trailer for How to Make a Killing and it tees up a wickedly funny crime tale about greed, revenge, and one very determined black sheep. If you’re into dark ...
Two men from North Texas have been charged over violent plans that included an armed coup on the Haitian island of Gonave, according to the Justice Department. Gavin Weisenburg, 21 years old of Allen, ...
Europe has tabled a counter proposal to the US-Russia draft peace plan for Ukraine. The document - drafted by Britain, France and Germany - uses the United States's 28-point plan as its basis, working ...
President Trump is pressing Kyiv to accept an outcome that yields to President Vladimir V. Putin’s demands. By Paul Sonne and Ivan Nechepurenko Paul Sonne reported from Berlin, and Ivan Nechepurenko ...
Exact Sciences, one of Madison’s largest biotech companies, has agreed to be acquired by Abbott Laboratories for $23 billion, the Illinois-based company announced Thursday.
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. President Donald Trump says President Volodymyr ...
The deal will add Exact Sciences' flagship colorectal cancer test Cologuard and early-stage breast cancer test Oncotype DX to Abbott's diagnostics portfolio, helping offset revenue declines from its ...
Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback